Compare PRAX & SNAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRAX | SNAP |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.1B | 7.7B |
| IPO Year | 2020 | 2017 |
| Metric | PRAX | SNAP |
|---|---|---|
| Price | $364.58 | $5.23 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 15 | 26 |
| Target Price | ★ $572.13 | $8.41 |
| AVG Volume (30 Days) | 401.0K | ★ 33.1M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 35.71 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $824,949,000.00 |
| Revenue This Year | N/A | $15.55 |
| Revenue Next Year | $7,758.26 | $9.82 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 103.95 |
| 52 Week Low | $37.25 | $3.81 |
| 52 Week High | $392.45 | $9.28 |
| Indicator | PRAX | SNAP |
|---|---|---|
| Relative Strength Index (RSI) | 58.43 | 53.54 |
| Support Level | $291.44 | $4.43 |
| Resistance Level | N/A | $5.76 |
| Average True Range (ATR) | 19.51 | 0.28 |
| MACD | 2.70 | -0.00 |
| Stochastic Oscillator | 76.31 | 41.83 |
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.
Snap is a technology company best known for its marquis social media application. Snapchat, a visual messaging application that has amassed hundreds of millions of users. The app was initially only used to communicate with family and friends through photographs and short videos (known as "Snaps"). Users can now enjoy augmented reality, or AR, lenses, content from famous creators and celebrities, updates about local events, and more. Although the app offers a paid subscription option with premium features, advertising sales produce most of the app's revenue. The firm also sells wearable devices called AR Spectacles, which can capture photos and videos overlayed with AR lenses, but these make up a small portion of Snap's overall sales.